These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 27993886)
21. Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C. Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N Int J Hematol; 2020 Sep; 112(3):331-340. PubMed ID: 32562089 [TBL] [Abstract][Full Text] [Related]
22. Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding. Li Y; Liang Q; Wu W; Hu X; Wang H; Wang X; Ding Q Res Pract Thromb Haemost; 2023 Jul; 7(5):102145. PubMed ID: 37601017 [TBL] [Abstract][Full Text] [Related]
23. Hereditary dysfibrinogenemia in a patient with thrombotic disease. Carrell N; Gabriel DA; Blatt PM; Carr ME; McDonagh J Blood; 1983 Aug; 62(2):439-47. PubMed ID: 6191801 [TBL] [Abstract][Full Text] [Related]
24. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers]. Saeki E; Matsuda M; Ichinose A; Samejima Y; Kasamatsu A; Ara R; Mitsuno K; Kihara T; Hara Y Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1229-35. PubMed ID: 4072586 [No Abstract] [Full Text] [Related]
25. Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen. Risman RA; Belcher HA; Ramanujam RK; Weisel JW; Hudson NE; Tutwiler V Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397467 [TBL] [Abstract][Full Text] [Related]
26. Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions. Luo M; Wei A; Xiang L; Yan J; Liao L; Deng X; Deng D; Cheng P; Lin F J Thromb Thrombolysis; 2018 Oct; 46(3):409-419. PubMed ID: 29869737 [TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations. Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772 [TBL] [Abstract][Full Text] [Related]
28. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K; Terasawa F; Okumura N Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100 [TBL] [Abstract][Full Text] [Related]
29. Fibrinogen and dysfibrinogenemia. Morse EE Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388 [TBL] [Abstract][Full Text] [Related]
30. Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications. Galanakis DK; Neerman-Arbez M; Brennan S; Rafailovich M; Hyder L; Travlou O; Papadakis E; Manco-Johnson MJ; Henschen A; Scharrer I Thromb Res; 2014 Jun; 133(6):1115-23. PubMed ID: 24679643 [TBL] [Abstract][Full Text] [Related]
31. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review. Li Y; Ding B; Wang X; Ding Q Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369 [TBL] [Abstract][Full Text] [Related]
32. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release. Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313 [TBL] [Abstract][Full Text] [Related]
33. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin. Okumura N; Haneishi A; Terasawa F Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936 [TBL] [Abstract][Full Text] [Related]
35. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites. Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960 [TBL] [Abstract][Full Text] [Related]
36. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum. Schorer AE; Singh J; Basara ML Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081 [TBL] [Abstract][Full Text] [Related]
37. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681 [TBL] [Abstract][Full Text] [Related]
40. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot. Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]